Magnolia Market Access at Evidence 360:
RWE, Pricing & Reimbursement Summit USA

June 26–27, 2025 |  Kimpton Hotel Palomar, Philadelphia

Magnolia Market Access is heading to the 2025 Evidence 360 Summit in Philadelphia to engage in high-impact conversations around the future of real-world evidence, drug pricing, and value-based access strategy. As manufacturers face increasing scrutiny around price negotiation, HTA alignment, and evidence standards, our team is helping clients navigate it all with confidence and clarity.

Featured Session

The Evolving Landscape of RWE in Drug Pricing Decisions
Beni Turner, Director of Real-World Clinical Insights, Magnolia Market Access
June 26, 2025 | 11:15 AM – 11:45 AM

As real-world evidence (RWE) gains momentum across regulatory and payer landscapes, its role in drug pricing and reimbursement decisions is becoming increasingly strategic. This 30-minute session explores how RWE is transforming traditional access models—moving from post-market support to a critical component of early pricing and market entry strategies.

Through real-world case studies and emerging policy developments, attendees will learn:

  • How regulators like the FDA, EMA, and HTA bodies are integrating RWE into access and pricing frameworks
  • The strategic value of RWE in value-based contracting, indication-specific pricing, and payer negotiations
  • New frontiers in RWE use—including social determinants of health and real-time outcomes dashboards
  • Actionable steps for embedding RWE into product development, launch planning, and market access design

Meet with Our Team

Magnolia Market Access leaders will be onsite and available for one-on-one meetings throughout the conference: Whether you’re refining a value story, preparing for launch, or managing policy-driven change, our team is here to support.

Let’s Align Evidence with Access Realities
Magnolia Market Access partners with biopharma teams to build actionable, payer-relevant strategies rooted in data, policy awareness, and market dynamics. If you’re attending Evidence 360 and facing growing pressure around value, pricing, and reimbursement—let’s talk.

Beni Turner

Director, Real World Clinical Insights

Sean McGonigal

VP, Growth

Request a Meeting

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.